Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Gisbert

Showing results (71-80 of 317) with videos related to

Pageof 32
Sort By:
Alimentary Pharmacology & Therapeutics|June 7, 2014
Letter: Persisting clinical symptoms in microscopic colitis in remissionF Fernández-Bañares, J P Gisbert
Revista Espanola De Enfermedades Digestivas|November 2, 2007
[Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review]L M Asenjo, J P Gisbert
Alimentary Pharmacology & Therapeutics|August 5, 2015
Letter: clarithromycin dose for H. pylori therapy remains unresolvedD Y Graham, J P Gisbert
Alimentary Pharmacology & Therapeutics|August 16, 2014
Letter: Bismuth quadruple therapy with Pylera for H. pylori infectionJ Molina-Infante, J P Gisbert
Alimentary Pharmacology & Therapeutics|June 3, 2016
Letter: anti-TNF in steroid-dependent ulcerative colitis - are the available data enough?M Barreiro-de Acosta, J P Gisbert
Gastroenterologia Y Hepatologia|March 5, 2004
[Systematic reviews and meta-analyses: how should they be performed, evaluated and used?]J P Gisbert, X Bonfil, X Bonfill
Alimentary Pharmacology & Therapeutics|October 4, 2014
Letter: predictors of severe disease in ulcerative colitis - the same or different in Crohn's disease?M Barreiro-de-Acosta, J P Gisbert
Alimentary Pharmacology & Therapeutics|November 12, 2013
Letter: infliximab in severe ulcerative colitis - is it useful for all patients?M Barreiro-de Acosta, J P Gisbert
Alimentary Pharmacology & Therapeutics|July 4, 2012
Letter: surgery for ulcerative colitis mostly follows anti-TNF drugs--a new 'therapeutic package'?M Barreiro-de Acosta, J P Gisbert
Alimentary Pharmacology & Therapeutics|December 5, 2013
Letter: acute severe ulcerative colitis - should all patients be treated equally?M Barreiro-de Acosta, J P Gisbert
Pageof 32

Showing results (71-80 of 317) with videos related to

Sort By:
Pageof 32
Alimentary Pharmacology & Therapeutics|June 7, 2014
Letter: Persisting clinical symptoms in microscopic colitis in remissionF Fernández-Bañares, J P Gisbert
Revista Espanola De Enfermedades Digestivas|November 2, 2007
[Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review]L M Asenjo, J P Gisbert
Alimentary Pharmacology & Therapeutics|August 5, 2015
Letter: clarithromycin dose for H. pylori therapy remains unresolvedD Y Graham, J P Gisbert
Alimentary Pharmacology & Therapeutics|August 16, 2014
Letter: Bismuth quadruple therapy with Pylera for H. pylori infectionJ Molina-Infante, J P Gisbert
Alimentary Pharmacology & Therapeutics|June 3, 2016
Letter: anti-TNF in steroid-dependent ulcerative colitis - are the available data enough?M Barreiro-de Acosta, J P Gisbert
Gastroenterologia Y Hepatologia|March 5, 2004
[Systematic reviews and meta-analyses: how should they be performed, evaluated and used?]J P Gisbert, X Bonfil, X Bonfill
Alimentary Pharmacology & Therapeutics|October 4, 2014
Letter: predictors of severe disease in ulcerative colitis - the same or different in Crohn's disease?M Barreiro-de-Acosta, J P Gisbert
Alimentary Pharmacology & Therapeutics|November 12, 2013
Letter: infliximab in severe ulcerative colitis - is it useful for all patients?M Barreiro-de Acosta, J P Gisbert
Alimentary Pharmacology & Therapeutics|July 4, 2012
Letter: surgery for ulcerative colitis mostly follows anti-TNF drugs--a new 'therapeutic package'?M Barreiro-de Acosta, J P Gisbert
Alimentary Pharmacology & Therapeutics|December 5, 2013
Letter: acute severe ulcerative colitis - should all patients be treated equally?M Barreiro-de Acosta, J P Gisbert
Pageof 32